Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

RBC Capital analyst Brian Abrahams maintained a Hold rating on Gilead Sciences (GILD – Research Report) on November 25 and set a price target ...

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...

Gilead (GILD) announced The New England Journal of Medicine, or NEJM, published the full results from the company’s pivotal Phase 3 PURPOSE 2 ...

A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published ...

Considering “health equity aspects”, Moupali Das highlighted the historic underrepresentation of disproportionately affected ...

Lead PURPOSE researcher Moupali Das, Vice President, Clinical Development, HIV Prevention & Pediatrics, designed the PURPOSE ...

The Mt. Gilead KOA Holiday, owned and operated by Chip and Bambi Hanawalt, has been named Kampgrounds of America, Inc.’s (KOA ...

Sac-TMT, also known as SKB264 or MK-2870, represents the first asset in Kelun’s multitarget, multibillion-dollar ADC ...

At the Nov. 18 Mount Gilead Village Council meeting, council member Kay Hines reported on the Finance/HR Committee’s ...

The leak occurred Monday afternoon on Mt. Gilead Road between Stegall Drive and Penny Lane, according to a statement from the ...

Casita Feliz, a nonprofit serving the Latino LGBTQ+ community in Fresno, recently celebrated its one-year anniversary ...